. Furthermore , it has been shown in vitro that 1,25(OH)2D3 at physiological concentrations can reduce accumulation of [3H]25-OH-D3 produced from 3H-vitamin D3 in liver homogenates and perfused livers from rachitic rats (10) . Taken collectively, these data support the hypothesis that 1,25(OH)2D can inhibit 25-OH-D synthesis. However, the data can equally well be explained by a 
Methods
Animal protocols. Male Sprague-Dawley rats (Hilltop Laboratories, Scottsdale, PA) weighing 100-125 g were fed ad lib. either standard rat chow (Wayne Lab Blox, Allied Mills, Inc., Chicago, IL, F-6) containing 4.41 U vitamin D3/g of food, 1.2% Ca and 0.99% P. or one of three synthetic vitamin D-deficient diets supplemented with vitamin D3 (100 U vitamin D3/d) and containing either 0.4, 1.2, or 2.4% Ca, and 1.2% P, respectively (14) . All animals were maintained on their respective diets for at least 10 d before experimentation and at the time of killing were 55 d of age in each experiment.
To examine the effect ofchronic 1, 25 24, 25(OH) [23,24(n) -3H]D3 (66 Ci/mmol) (Amersham Corp., Arlington Heights, IL) in 20 gl of ethanol were added to 2 ml of serum and the serum was allowed to sit at room temperature for 10 min. Samples were then extracted twice with 3 vol of peroxide-free diethylether (J. T. Baker Chemical Corp., Phillipsburg, NJ) followed by extraction with 4 vol of dichloromethane/methanol (3: 1). After mixing for 5 min, 1 additional vol of methanol was added, the samples were shaken for an additional 2 min and the methanol-aqueous layer was removed by aspiration. The remaining solution was washed with 0.1 M sodium phosphate buffer (pH 10.5) twice. The remaining organic phase was combined with the ether extracts, dried under nitrogen, applied to a Sephadex LH-20 column (0.6 X 15 cm) and eluted in hexane/chloroform/methanol (90:10:10). The 25-OH-D3 fraction from LH-20 chromatography was applied to a Waters Radial Compression Separation System (Waters Associates) using an 8-mm silica radial compression column (IO Am particle size), a solvent system of isopropanol/hexane (4:96) and a flow rate of 3 ml/min. 25-OH-D3 was quantitated using a competitive protein binding assay based on vitamin D-deficient rat serum as previously described (17) . Inter-and intraassay coefficients of variation for this assay are 16 and 10%, respectively.
The dihydroxyvitamin D3 fraction from LH-20 chromatography was applied to two MPorosil columns in series and eluted with a solvent system of isopropanol/hexane (10:90) at a flow rate of 2 ml/min. The 1,25(OH)2D3 fraction from this chromatography was quantitated with the chick intestinal cytosol receptor assay as described by Shepard et al. (18) . Inter-and intraassay coefficients of variation for this assay are 11 and 9%, respectively. The 24,25(OH)2D3 fraction from the two MPorosil columns was further chromatographed on a Zorbax-Sil column with a solvent system of isopropanol/dichloromethane (2:98) and a flow rate of 2 ml/min (19) . 24,25-Dihydroxyvitamin D3 was quantitated using a competitive protein binding assay based on vitamin D deficient rat serum as previously described (16) . Inter-and intraassay coefficients of variation for this assay are 20 and 12%, respectively.
For measurement of the MCR, the serum concentration of [3HJ25-OH-D3 was measured in the following manner. Approximately 1.2 Mg ofchromatographically purified 25-OH-D3 in 20 Ml ofethanol was added to each 2-ml serum sample to determine recovery. Samples were extracted and chromatographed using a C-18 Sep-Pak (Waters Associates) as described by Reinhardt et al. (12) followed by chromatography on a silica Sep-Pak (Waters Associates). Samples were applied to the silica Sep-Paks in isopropanol/hexane (4:96) and eluted with 8 ml of the same solvent. The 25-OH-D fraction was then chromatographed using an 8-mm silica radial compression column (10 Am particle size), a solvent system of isopropanol/hexane (3:97) and a flow rate of 3.5 ml/min, followed by further high performance liquid chromatography using a MBondapak C-18 column, a solvent system of water/methanol (22:78) and a flow rate of 2.0 ml/min. The 25-OH-D3 fractions from the MBondapack C-18 column were dried under nitrogen and the amount of 3H determined by scintillation counting. Calculation of recovery of 25-OH-D3 added to the serum was accomplished by comparison of the ultraviolet light absorbance maximum at 254 nm of the sample to that of 25-OH-D3 standards. Recovery of 25-OH-D3 averaged 51%. The intraassay coefficient of variation for measurement of [3H]25-OH-D3 in serum is 5.9%
(n = 7).
To insure that the chromatographic procedures used to purify Ml of ethanol was added to each sample of a group (n = 10) of serum samples (2.0 ml each) drawn from a pool of serum collected from four rats that had been infused with [3H]25-OH-D3 for 12 d. The serum samples were extracted and chromatographed as described above with the exception that after the reverse-phase chromatography step (i.e., the MBondapak column) the 25-OH-D3 fractions were rechromatographed using a Zorbax-Sil column, a solvent system of isopropanol/dichloromethane (2:98) and a flow rate of 2 ml/min. After each chromatographic step (i.e., after the first straight phase, after the reverse phase, and after the second straight phase) a fraction of the sample was removed, the 3H in the fraction quantitated, and from the recovery at that step, the con- To insure a margin of safety, however, we choose to use the straight phase followed by reverse-phase high performance liquid chromatographic system for all routine analyses.
Serum calcium was measured using atomic absorption spectroscopy after dilution (1/50) of serum with LaCl3. Serum inorganic phosphate (Pi) was measured using the method of LeBel et al. (20) .
Calculations The MCR of25-OH-D3, defined as the volume ofblood cleared completely and irreversibly of 25-OH-D3 per unit time (16) Fig. 1 . As the serum concentration of 1,25(OH)2D3 was increased to 150 pg/ml, there was a more or less linear decrease in the serum level of *25-OH-D3. However, for higher serum concentrations of 1,25(OH)2D3 (up to 225 pg/ml), no further reduction in serum 25-OH-D3 was observed.
After 7 and 12 d ofconstant 1,25(OH)2D3 infusion the serum concentration of 24,25(OH)2D3 was also significantly reduced (P < 0.00 1) (Table I) Table I) . At 3, 7, and 12 d after beginning infusion of 1,25(OH)2D3 serum calcium was significantly (P < 0.001) increased in the 50-and 75-pmol/d dose groups. In the 25-pmol/ d dose groups, although there was a trend for serum calcium to be increased, the difference did not reach significance (P = 0.250).
To determine if the reduction in serum 25-OH-D3 brought The serum concentration of 1,25(OH)2D3 in vehicle-infused animalsdecreased from 152±7 pg/ml to 12 1±pg/ml (P <0.001) when dietary calcium was increased from 0.4% to 2.4% (Table  IV) . 1,25-Dihydroxyvitamin D3 infusion increased (P < 0.005) serum 1,25(OH)2D3 within each ofthe diet groups, although the increment in increase was substantially less in the 0.4% dietary calcium group (23 pg/ml) than in the 2.4% dietary calcium group (61 pg/ml).
The serum concentration of 25-OH-D3 in vehicle infused animals was identical (24±ng/nil) when dietary calcium was 0.4 and 1.2% but was higher (36±ng/ml, P < 0.001) when dietary calcium was increased to 2.4% (Table IV) . Regardless of the concentration of25-OH-D3 in vehicle infused animals however, chronic 1,25(OH)2D3 infusion reduced serum 25-OH-D3 (P < 0.001) approximately the same amount (viz. 10-14 ng/ml) in each diet group.
The serum concentration of 24,25(OH)2D3 in vehicle infused animals was similar, 10.9±0.6 and 11.4±1.1 ng/ml, when dietary calcium was 1.2 and 2.4%, respectively, but was lower, 6.8±0.9 ng/ml (P < 0.001), when dietary calcium was reduced to 0.4% (Table IV) . In each dietary group, chronic 1,25(OH)2D3 infusion significantly reduced serum 24,25(OH)2D3 (P < 0.001). 
